Kazuhiko Ohashi Selected Research

Kazuhiko Ohashi Research Topics

Disease

19	Infections 01/2020 - 05/2003
16	Disease Progression 09/2023 - 07/2006
15	Neoplasms (Cancer) 06/2023 - 03/2002
15	Deltaretrovirus Infections (BLV Infection) 01/2023 - 11/2003
11	Persistent Infection 09/2023 - 09/2011
9	Marek Disease (Marek's Disease) 01/2024 - 06/2006
7	Melanoma (Melanoma, Malignant) 06/2023 - 01/2016
6	Paratuberculosis (Johne's Disease) 10/2022 - 01/2016
4	Lymphocytosis 03/2016 - 07/2003
4	Lymphoma (Lymphomas) 08/2014 - 12/2002
4	Tick Infestations 12/2013 - 02/2003
2	Carcinogenesis 01/2024 - 11/2021
2	Cattle Diseases (Bovine Diseases) 01/2022 - 07/2014
2	Bacterial Infections (Bacterial Infection) 01/2020 - 01/2019
2	Chronic Disease (Chronic Diseases) 10/2019 - 01/2017
2	Disease Resistance 08/2012 - 03/2007
2	Communicable Diseases (Infectious Diseases) 08/2003 - 03/2002
1	Listeriosis (Listeria Infection) 07/2023
1	Respiratory Tract Infections (Respiratory Tract Infection) 03/2023
1	Diarrhea 01/2023
1	Adenocarcinoma 01/2023
1	Thrombocytopenia (Thrombopenia) 01/2023
1	Osteosarcoma (Osteogenic Sarcoma) 01/2020
1	Horse Diseases (Horse Disease) 01/2020
1	Inflammation (Inflammations) 02/2019
1	Virus Diseases (Viral Diseases) 01/2019
1	Anaplasmosis 01/2017
1	Sarcoma (Soft Tissue Sarcoma) 01/2017
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2016
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2016
1	Coinfection 10/2013
1	Porcine Reproductive and Respiratory Syndrome (PRRS) 06/2013
1	Babesiosis (Piroplasmosis) 10/2012
1	Foot-and-Mouth Disease 10/2009
1	Glioma (Gliomas) 05/2008
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 08/2006
1	Avian Leukosis 06/2006
1	Bites and Stings (Sting) 03/2006

Drug/Important Bio-Agent (IBA)

13	LigandsIBA 01/2023 - 09/2011
13	CytokinesIBA 01/2023 - 03/2002
11	B7-H1 AntigenIBA 06/2023 - 09/2011
10	Proteins (Proteins, Gene)FDA Link 01/2024 - 12/2002
7	Messenger RNA (mRNA)IBA 02/2015 - 07/2003
6	Monoclonal AntibodiesIBA 07/2023 - 02/2003
6	AntibodiesIBA 01/2023 - 01/2016
6	AntigensIBA 10/2022 - 03/2006
6	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2022 - 09/2005
6	DNA (Deoxyribonucleic Acid)IBA 05/2014 - 05/2003
5	Immune Checkpoint InhibitorsIBA 06/2023 - 01/2016
5	Dinoprostone (PGE2)FDA Link 01/2022 - 01/2018
5	VaccinesIBA 06/2016 - 08/2003
4	Immune Checkpoint ProteinsIBA 09/2023 - 01/2017
3	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 01/2020 - 01/2018
3	Interferon-gamma (Interferon, gamma)IBA 01/2018 - 01/2007
2	MucinsIBA 01/2023 - 05/2012
2	Antiviral Agents (Antivirals)IBA 01/2023 - 01/2019
2	ProstaglandinsIBA 10/2022 - 01/2019
2	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2021 - 01/2020
2	Blocking AntibodiesIBA 01/2018 - 01/2017
2	Immunoglobulin M (IgM)IBA 08/2014 - 08/2006
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 05/2012 - 05/2009
2	Trans-Activators (Trans-Acting Factor)IBA 11/2003 - 12/2002
1	Protein Isoforms (Isoforms)IBA 01/2024
1	Complementary DNA (cDNA)IBA 07/2023
1	Viral VaccinesIBA 03/2023
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2023
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2023
1	InterferonsIBA 01/2023
1	CTLA-4 AntigenIBA 10/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Estradiol (Delestrogen)FDA LinkGeneric 01/2022
1	Interleukin-2 (IL2)IBA 12/2021
1	Oncogene Proteins (Oncogene Protein)IBA 11/2021
1	Transcription Factors (Transcription Factor)IBA 11/2021
1	Protein SIBA 11/2021
1	Transforming Growth Factor beta (TGF-beta)IBA 01/2021
1	vesatolimodIBA 01/2021
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2021
1	Interleukin-10 (Interleukin 10)IBA 01/2020
1	Meloxicam (Mobic)FDA LinkGeneric 01/2019
1	Prostaglandin E Receptors (Prostaglandin E Receptor)IBA 01/2019
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 01/2019
1	Tuberculin (PPD)IBA 01/2018
1	PerforinIBA 03/2016
1	CystatinsIBA 12/2013
1	Oligonucleotide ProbesIBA 10/2013
1	Proline (L-Proline)FDA Link 06/2013
1	Histocompatibility Antigens Class IIIBA 01/2013
1	MineralsIBA 10/2012
1	Protozoan DNAIBA 01/2009
1	NucleotidesIBA 05/2008
1	Indicators and Reagents (Reagents)IBA 01/2007
1	gamma-AIBA 01/2007
1	Peptides (Polypeptides)IBA 12/2005
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 09/2005
1	DNA VaccinesIBA 11/2003

Therapy/Procedure

11	Therapeutics 06/2023 - 07/2013
9	Immunotherapy 01/2023 - 09/2011
1	Radiotherapy 06/2023
1	Transjugular Intrahepatic Portasystemic Shunt 09/2007